Prediction of birth weight small for gestational age with and without preeclampsia by angiogenic markers: an Odense Child Cohort study

References

• Lawn JE, Blencowe H, Oza S, et al. Every newborn: progress, priorities, and potential beyond survival. Lancet. 2014;384:189–205.
   PubMed Web of Science ®Google Scholar
• Doctor BA, O’Riordan MA, Kirchner HL, et al. Perinatal correlates and neonatal outcomes of small for gestational age infants born at term gestation. Am J Obstet Gynecol. 2001;185:652–659.
   PubMed Web of Science ®Google Scholar
• Andraweera PH, Dekker GA, Roberts CT. The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum Reprod Update. 2012;18:436–457.
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785–799.
   PubMed Web of Science ®Google Scholar
• Habli M, Levine RJ, Qian C, et al. Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Am J Obstet Gynecol. 2007;197:406.e1–406.e7.
   Web of Science ®Google Scholar
• Hentges CR, Silveira RC, Procianoy RS. Angiogenic and antiangiogenic factors in preterm neonates born to mothers with and without preeclampsia. Am J Perinatol. 2015;32:1185–1190.
   PubMed Web of Science ®Google Scholar
• Ota E, Ganchimeg T, Morisaki N, et al. Risk factors and adverse perinatal outcomes among term and preterm infants born small-for-gestational-age: secondary analyses of the WHO multi-country survey on maternal and newborn health. PLOS ONE. 2014;9:e105155.
   PubMed Web of Science ®Google Scholar
• Gardosi J. New definition of small for gestational age based on fetal growth potential. Horm Res. 2006;65:15–18.
   PubMedGoogle Scholar
• Maulik D. Fetal growth compromise: definitions, standards, and classification. Clin Obstet Gynecol. 2006;49:214–218.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Vintzileos AM. Distinguishing pathological from constitutional small for gestational age births in population-based studies. Early Hum Dev. 2009;85:653–658.
   PubMed Web of Science ®Google Scholar
• Odibo AO, Francis A, Cahill AG, et al. Association between pregnancy complications and small-for-gestational-age birth weight defined by customized fetal growth standard versus a population-based standard. J Matern Fetal Neonatal Med. 2011;24:411–417.
   PubMed Web of Science ®Google Scholar
• Moussa HN, Wu ZH, Han Y, et al. Customized versus population fetal growth norms and adverse outcomes associated with small for gestational age infants in a high-risk cohort. Am J Perinatol. 2015;32:621–626.
   PubMed Web of Science ®Google Scholar
• Smith NA, Bukowski R, Thomas AM, et al. Identification of pathologically small fetuses using customized, ultrasound and population-based growth norms. Ultrasound Obstet Gynecol. 2014;44:595–599.
   PubMed Web of Science ®Google Scholar
• Chiossi G, Pedroza C, Costantine MM, et al. Customized vs population-based growth charts to identify neonates at risk of adverse outcome: systematic review and Bayesian meta-analysis of observational studies. Ultrasound Obstet Gynecol. 2017;50:156–166.
   PubMed Web of Science ®Google Scholar
• Ego A, Subtil D, Grange G, et al. Customized versus population-based birth weight standards for identifying growth restricted infants: a French multicenter study. Am J Obstet Gynecol. 2006;194:1042–1049.
   PubMed Web of Science ®Google Scholar
• Vrachnis N, Kalampokas E, Sifakis S, et al. Placental growth factor (PlGF): a key to optimizing fetal growth. J Matern Fetal Neonatal Med. 2013;26:995–1002.
   PubMed Web of Science ®Google Scholar
• Nucci M, Poon LC, Demirdjian G, et al. Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11–13 weeks’ gestation in normal and pathological pregnancies. Fetal Diagn Ther. 2014;36:106–116.
   PubMed Web of Science ®Google Scholar
• Girardi G, Yarilin D, Thurman JM, et al. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med. 2006;203:2165–2175.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–683.
   PubMed Web of Science ®Google Scholar
• Verlohren S, Herraiz I, Lapaire O, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension. 2014;63:346–352.
   PubMed Web of Science ®Google Scholar
• Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1:PlGF Ratio in women with suspected preeclampsia. N Engl J Med. 2016;374:13–22.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski S, Dołęgowska B, Kwiatkowska E, et al. Do the physiological aging of the placenta and the changes in angiogenesis marker sFlt-1 and PlGF concentrations predispose patients to late-onset preeclampsia? J Matern Fetal Neonatal Med. 2017:1–10. doi:10.1080/14767058.2017.1369517. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Andersen LB, Frederiksen-Møller B, Work Havelund K, et al. Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio: an inter-assay comparison. J Am Soc Hypertens. 2015;9:86–96.
   PubMed Web of Science ®Google Scholar
• Diguisto C, Piver E, Gouge AL, et al. First trimester uterine artery doppler, sFlt-1 and PlGF to predict preeclampsia in a high-risk population. J Matern Fetal Neonatal Med. 2017;30:1514–1519.
   PubMed Web of Science ®Google Scholar
• Kenny LC, Black MA, Poston L, et al. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the screening for pregnancy endpoints (SCOPE) international cohort study. Hypertension. 2014;64:644–652.
   PubMed Web of Science ®Google Scholar
• Navaratnam K, Abreu P, Clarke H, et al. Evaluation of agreement of placental growth factor (PlGF) tests and the soluble FMS-like tyrosine kinase 1 (sFlt-1)/PlGF ratio, comparison of predictive accuracy for pre-eclampsia, and relation to uterine artery Doppler and response to aspirin. J Matern Fetal Neonatal Med. 2017:1–9. doi:10.1080/14767058.2017.1373760. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Steinberg G, Lee C, Rauh-Hain JA, et al. Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies. Am J Obstet Gynecol. 2010;202:299.e1–299.e7.
   Web of Science ®Google Scholar
• Allen R, Aquilina J. Prospective observational study to determine the accuracy of first-trimester serum biomarkers and uterine artery dopplers in combination with maternal characteristics and arteriography for the prediction of women at risk of preeclampsia and other adverse pregnancy outcomes. J Matern Fetal Neonatal Med. 2018;31:2789–2806.
   PubMed Web of Science ®Google Scholar
• Triunfo S, Parra-Saavedra M, Rodriguez-Sureda V, et al. Angiogenic factors and doppler evaluation in normally growing fetuses at routine third-trimester scan: prediction of subsequent low birth weight. Fetal Diagn Ther. 2016;40:13–20.
   PubMed Web of Science ®Google Scholar
• Rizos D, Eleftheriades M, Karampas G, et al. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study. Eur J Obstet Gynecol Reprod Biol. 2013;171:225–230.
   PubMed Web of Science ®Google Scholar
• Triunfo S, Crovetto F, Rodriguez-Sureda V, et al. Changes in uterine artery doppler velocimetry and circulating angiogenic factors in the first half of pregnancies delivering a small-for-gestational-age neonate. Ultrasound Obstet Gynecol. 2017;49:357–363.
   PubMed Web of Science ®Google Scholar
• Birdir C, Fryze J, Frölich S, et al. Impact of maternal serum levels of visfatin, AFP, PAPP-A, sFlt-1 and PlGF at 11–13 weeks gestation on small for gestational age births. J Matern Fetal Neonatal Med. 2017;30:629–634.
   PubMed Web of Science ®Google Scholar
• Kyhl HB, Jensen TK, Barington T, et al. The Odense child cohort: aims, design, and cohort profile. Paediatr Perinat Epidemiol. 2015;29:250–258.
   PubMed Web of Science ®Google Scholar
• Luef BM, Andersen LB, Renäult KM, et al. Validation of hospital discharge diagnoses for hypertensive disorders of pregnancy. Acta Obstet Gynecol Scand. 2016;95:1288–1294.
   PubMed Web of Science ®Google Scholar
• Marsál K, Persson PH, Larsen T, et al. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 1996;85:843–848.
   PubMed Web of Science ®Google Scholar
• Sterpu I, Anfelter P, Wray S, et al. The association of second trimester biomarkers in amniotic fluid and fetal outcome. J Matern Fetal Neonatal Med. 2018:1–6. doi:10.1080/14767058.2018.1469127. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Raia-Barjat T, Prieux C, Gris JC, et al. Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study. J Matern Fetal Neonatal Med. 2017:1–10. doi:10.1080/14767058.2017.1378325. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Poon LC, Lesmes C, Gallo DM, et al. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 19–24 weeks. Ultrasound Obstet Gynecol. 2015;46:437–445.
   PubMed Web of Science ®Google Scholar
• Bakalis S, Gallo DM, Mendez O, et al. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30–34 weeks. Ultrasound Obstet Gynecol. 2015;46:208–215.
   PubMed Web of Science ®Google Scholar
• Lesmes C, Gallo DM, Gonzalez R, et al. Prediction of small-for-gestational-age neonates: screening by maternal serum biochemical markers at 19–24 weeks. Ultrasound Obstet Gynecol. 2015;46:341–349.
   PubMed Web of Science ®Google Scholar
• Bakalis S, Peeva G, Gonzalez R, et al. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30–34 weeks. Ultrasound Obstet Gynecol. 2015;46:446–451.
   PubMed Web of Science ®Google Scholar
• Andersen LB, Dechend R, Jørgensen JS, et al. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense child cohort. Hypertens Pregnancy. 2016;35:405–419.
   PubMed Web of Science ®Google Scholar